COVID-19 and Metabolic Syndrome: A Call To Action

The COVID-19 pandemic presents an unprecedented health crisis to the entire world. As in many other instances, people with metabolic syndrome (obesity, hypertension, hyperlipidemia, and diabetes) are apparently paying a very high price.

Data, albeit mostly uncontrolled for potential confounding factors, are, unfortunately, showing that people with underlying metabolic conditions are at higher risk of both contracting COVID-19 and having a worse prognosis. At the same time, in such a sudden health crisis, it is not clear what the most appropriate management would be and thus most likely these patients may not be receiving the most appropriate care when hospitalized.

Metabolism is committed to playing a positive role during this crisis. We the Editors invite the submission of papers addressing this topic and remain committed to a fast-track quality process for the review of any relevant research on COVID-19 and guarantee free access to accepted papers.

Our aim is to serve as a fast, trusted and authoritative platform for disseminating new knowledge on the components of the metabolic syndrome in relation to the COVID-19 pandemic, within the context of our broader aim of effectively serving our suffering fellow human beings all around the world.

Thus, with this call, Metabolism invites scientists from our global community to submit their research in this field to our journal.

Christos Mantzoros, MD DSc